Illumina, the leading producer of gene-sequencing machines, announced Sunday that it would sell Grail, a cancer test developer that it purchased for $7.1 billion in 2021. The move came two days after Illumina lost its case in a federal appeals court, which largely upheld a Federal Trade Commission ruling that Illumina should unwind its deal …
COP28: At Dubai’s Climate Summit, Protesters Test the Limits
A woman dressed as a dugong, a rare marine mammal, beseeched passers-by to end the burning of fossil fuels. Protesters wiped away tears as they recited the names of Palestinians killed by Israel’s bombardment of Gaza. And human rights activists staged a fraught demonstration in support of political prisoners held less than 100 miles away …